Chao Xu

Title: Chao Xu - Innovator in Drug Synthesis

Introduction

Chao Xu is a notable inventor based in Jiaxing, China. He has made significant contributions to the field of drug synthesis, particularly through his innovative methods in preparing pharmaceutical intermediates. His work has implications for the development of important therapeutic agents.

Latest Patents

Chao Xu holds a patent for a method titled "Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone." This patent discloses a novel approach to synthesizing trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, which is crucial for the production of halofuginone. The method utilizes amino-substituted pentanal and a thiazolyl sulfoxide compound as raw materials, employing Mislow-Evans rearrangement reaction and subsequent Lewis acid catalysis. This innovative technique achieves high yields and stable qualities, providing a new reference route for synthesis while avoiding the use of expensive metal catalysts.

Career Highlights

Chao Xu is associated with Chengda Pharmaceuticals Co., Ltd., where he has been instrumental in advancing drug synthesis methodologies. His expertise and innovative approaches have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Chao Xu has collaborated with notable colleagues, including Yu Feng and Hong Xu. Their combined efforts contribute to the ongoing advancements in drug synthesis and pharmaceutical development.

Conclusion

Chao Xu's contributions to drug synthesis through his innovative patent highlight his role as a key inventor in the pharmaceutical field. His work not only enhances the efficiency of drug production but also opens new avenues for research and development in therapeutic agents.